Moreover, using the B16-F10 melanoma model, the authors showed that IL-21 produced by in vitro differentiated Th17 cells also increases the frequency of CX3CR1+ CD8+ T cells in the tumor, which in turn was associated with reduced tumor burden (63). The gene discussed is IL21; the disease is melanoma.